Norway
· Delayed Price · Currency is NOK Nordhealth AS Statistics
Total Valuation
Nordhealth AS has a market cap or net worth of NOK 2.83 billion. The enterprise value is 2.60 billion.
| Market Cap | 2.83B |
| Enterprise Value | 2.60B |
Important Dates
The last earnings date was Friday, April 11, 2025.
| Earnings Date | Apr 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nordhealth AS has 79.07 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 79.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 48.61% |
| Owned by Institutions (%) | 19.22% |
| Float | 38.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 74.85 |
| PS Ratio | 5.27 |
| PB Ratio | 3.27 |
| P/TBV Ratio | 12.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 130.22 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -28.80 |
| EV / Sales | 4.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -69.68 |
Financial Position
The company has a current ratio of 2.99
| Current Ratio | 2.99 |
| Quick Ratio | 2.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -208.81 |
Financial Efficiency
Return on equity (ROE) is -9.81% and return on invested capital (ROIC) is -6.17%.
| Return on Equity (ROE) | -9.81% |
| Return on Assets (ROA) | -5.52% |
| Return on Invested Capital (ROIC) | -6.17% |
| Return on Capital Employed (ROCE) | -10.46% |
| Revenue Per Employee | 1.31M |
| Profits Per Employee | -219,613 |
| Employee Count | 411 |
| Asset Turnover | 0.52 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.47% in the last 52 weeks. The beta is 0.46, so Nordhealth AS's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +3.47% |
| 50-Day Moving Average | 38.06 |
| 200-Day Moving Average | 37.33 |
| Relative Strength Index (RSI) | 44.12 |
| Average Volume (20 Days) | 2,929 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nordhealth AS had revenue of NOK 537.23 million and -90.26 million in losses. Loss per share was -1.14.
| Revenue | 537.23M |
| Gross Profit | 184.25M |
| Operating Income | -90.87M |
| Pretax Income | -78.08M |
| Net Income | -90.26M |
| EBITDA | -10.24M |
| EBIT | -90.87M |
| Loss Per Share | -1.14 |
Balance Sheet
The company has 230.79 million in cash and n/a in debt, giving a net cash position of 230.79 million or 2.92 per share.
| Cash & Cash Equivalents | 230.79M |
| Total Debt | n/a |
| Net Cash | 230.79M |
| Net Cash Per Share | 2.92 |
| Equity (Book Value) | 866.06M |
| Book Value Per Share | 10.95 |
| Working Capital | 213.21M |
Cash Flow
In the last 12 months, operating cash flow was 21.74 million and capital expenditures -59.04 million, giving a free cash flow of -37.31 million.
| Operating Cash Flow | 21.74M |
| Capital Expenditures | -59.04M |
| Free Cash Flow | -37.31M |
| FCF Per Share | -0.47 |
Margins
Gross margin is 34.30%, with operating and profit margins of -16.92% and -16.80%.
| Gross Margin | 34.30% |
| Operating Margin | -16.92% |
| Pretax Margin | -14.53% |
| Profit Margin | -16.80% |
| EBITDA Margin | -1.91% |
| EBIT Margin | -16.92% |
| FCF Margin | n/a |
Dividends & Yields
Nordhealth AS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.19% |
| FCF Yield | -1.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nordhealth AS has an Altman Z-Score of 14.16.
| Altman Z-Score | 14.16 |
| Piotroski F-Score | n/a |